Biomarkers in acute lung injury: are we making progress?
- PMID: 18664801
- PMCID: PMC2679214
- DOI: 10.1097/CCM.0b013e318181052a
Biomarkers in acute lung injury: are we making progress?
Comment on
-
Pentraxin 3 in acute respiratory distress syndrome: an early marker of severity.Crit Care Med. 2008 Aug;36(8):2302-8. doi: 10.1097/CCM.0b013e3181809aaf. Crit Care Med. 2008. PMID: 18596636 Clinical Trial.
References
-
- Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med. 2000;342:1334–1349. - PubMed
-
- Donnelly SC, Strieter RM, Reid PT, et al. The association between mortality rates and decreased concentrations of interleukin-10 and interleukin-1 receptor antagonist in the lung fluids of patients with the adult respiratory distress syndrome. Ann Intern Med. 1996;125:191–196. - PubMed
-
- Geiser T, Atabai K, Jarreau PH, Ware LB, Pugin J, Matthay MA. Pulmonary edema fluid from patients with acute lung injury augments in vitro alveolar epithelial repair by an IL-1beta-dependent mechanism. Am J Respir Crit Care Med. 2001;163:1384–1388. - PubMed
-
- Tremblay LN, Miatto D, Hamid Q, Govindarajan A, Slutsky AS. Injurious ventilation induces widespread pulmonary epithelial expression of tumor necrosis factor-alpha and interleukin-6 messenger RNA. Crit Care Med. 2002;30:1693–1700. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
